Explorer les evidences

3,93 %In Sector 8, the morbidity rate for severe malaria among children under 5 years of age was 3.93% in 2022.

Burkina Fasopaludismeobservé 2022HAL · Unilimdocument de 110 observations

40 %In children with inconclusive results (PfHRP2+/pLDH- only), previous antimalarial treatment was reported in 16 children with malaria negative microscopy (16/40; 40%).

Burkina Fasopaludismepublié 2019PloS oneeurope_pmcdocument de 12 observations

81,8 %For secundigravidae, a prediction model using IL-10 and sTNF-RII had a sensitivity of 81.8% and specificity of 100.0% for diagnosing malaria during pregnancy.

Burkina Fasopaludismepublié 2017Biomarker researcheurope_pmcdocument de 5 observations

18,6 %In Nanoro, Burkina Faso, the Pfdhfr/Pfdhps quintuple mutant IRN-436A437G rose from 18.6% in 2010–2012 to 58.3% in 2020.

Burkina Fasopaludismeobservé 2010-2012publié 2024Scientific reportsPubMeddocument de 4 observations

33,7 %The frequency of the pfcrt76T mutant allele was 33.7% in the study area.

Burkina Fasopaludismeobservé 2012 and 2013HAL · Unilimdocument de 2 observations

67 casesOf the 306 patients, 67 had Plasmodium falciparum malaria, including two mixed infections with Plasmodium malariae.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

The sporozoite infection rate for An. arabiensis was higher than An. gambiae s.s. at both Dioulassoba and Kodeni.

Burkina Fasopaludismeobservé 2008publié 2012Parasites & vectorseurope_pmcdocument de 5 observationsDOI 10.1186/1756-3305-5-127

54 %Malaria prevalence was 54.0% in primigravidae.

Burkina Fasopaludismepublié 2020Clinical nutrition (Edinburgh, Scotland)europe_pmcdocument de 7 observationsDOI 10.1016/j.clnu.2019.01.016

Haemoglobin level was influenced by msp2 family with patients harboring the FC27 allele showing lower haemoglobin level than mono-infected individuals by the 3D7 allele.

Burkina Fasopaludismepublié 2019Scientific reportseurope_pmcdocument de 4 observationsDOI 10.1038/s41598-018-36493-y

5 patientsRescue therapy was required in 5 out of 8 teenaged patients treated with SAR97276A twice daily (0.25 mg/kg) for 3 days.

Burkina Fasopaludismepublié 2017Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/s12936-017-1832-x

55,8 %Vaccine efficacy of RTS,S/AS01 against clinical malaria was 55.8% in the per-protocol population.

Burkina Fasopaludismepublié 2011The New England journal of medicineeurope_pmcdocument de 7 observationsDOI 10.1056/nejmoa1102287

97,4 %The specificity of db-PCR-NALFIA compared to the initial diagnosis in the laboratory was 97.4%.

Burkina Fasopaludismepublié 2012Journal of clinical microbiologyeurope_pmcdocument de 10 observations

1,7 visitsThe mean visit number on which the DHFR-TS-ELISA was still positive after treatment was 1.7 visits with a 95% confidence interval of 1.1 to 2.3.

Burkina Fasopaludismepublié 2012Tropical medicine & international health : TM & IHeurope_pmcdocument de 6 observations

23 %Sabatinelli et al. (1986) estimated that 23% of malaria-related deaths recorded worldwide are attributable to environmental factors.

Burkina Fasopaludismeobservé 1986HAL · Unilimdocument de 110 observations

1 visitsThe median visit number on which microscopy was still positive after treatment was 1, with a range of 1 to 3.

Burkina Fasopaludismepublié 2012Tropical medicine & international health : TM & IHeurope_pmcdocument de 6 observations

The prevalence of stunting, low-MUAC-for-age or being underweight did not differ between groups for any of the three years.

Burkina Faso · Malipaludismeobservé 2017-2019publié 2022Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/s12936-022-04077-x

98,6 %The QBC-test has sensitivity of 98.6% and specificity of 99.6% according to thick and thin Giemsa-stained blood films as gold standard.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

14,3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 14.3 in the group receiving 100 μg ProC6C-AlOH (G2C).

Burkina Fasopaludismeobservé D180HAL · Unilimdocument de 39 observations

50 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 50% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobservé post-2021HAL · Unilimdocument de 105 observations

332 patients332 patients withdrew from an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

0,55 episodes_per_person_yearIn the 14 months after the first dose of vaccine, the incidence of first episodes of clinical malaria in the first 6000 children aged 5 to 17 months was 0.55 episodes per person-year in the control group.

Burkina Fasopaludismepublié 2011The New England journal of medicineeurope_pmcdocument de 7 observationsDOI 10.1056/nejmoa1102287

46 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of approximately 46% in children aged 5–17 months.

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

0,4 proportionThe kdr frequency varied from 0.4 to 0.97 in Anopheles gambiae populations from the Sudanian region of Burkina Faso from August to October 2006.

Burkina Fasopaludismeobservé August to October 2006publié 2009Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 5 observations

0,29 odds_ratioIn Burkina Faso, the odds of malaria were lower 1 month post-SMC administration, with an odds ratio of 0.29, after controlling for seasonal factors, age, sex, net use and other variables.

Burkina Fasopaludismepublié 2022BMJ global healthPubMeddocument de 8 observations

Full susceptibility to organophosphates was observed in Vallée du Kou (VK).

Burkina Fasopaludismepublié 2013Geneeurope_pmcdocument de 6 observations